Advertisement

Pharmaceutical Chemistry Journal

, Volume 46, Issue 9, pp 553–564 | Cite as

Structure–activity relationship in a series of natural and synthetic inhibitors of 5-lipoxygenase catalytic activity

  • V. R. Khairullina
  • I. A. Taipov
  • A. Ya. Gerchikov
  • F. S. Zarudii
Article
  • 129 Downloads

Structural features characteristic of high-, medium-, and low-efficiency inhibitors of 5-lipoxygenase (5-LOG) catalytic activity were established. The degree of their influence on the inhibition efficiency was assessed. Two models (M1 and M2) were constructed for the prediction and recognition of the efficiency intervals of 5-LOG inhibitors. The confidence level of activity prediction for M1 and M2 reached 90 and 70%, respectively. The revealed structural features could be used for constructing highly selective inhibitors of 5-LOG catalytic activity.

Key words

5-lipoxygenase structure—activity relationship inhibitors of catalytic activity 

References

  1. 1.
    J. C. Boyington, B. J. Gaffney, and L. M. Amzel, Pharmacology, 38, 199–205 (1985).Google Scholar
  2. 2.
    E. Pontiki and D. Hadjipavlou-Litina, Curr. Enzyme Inhib., 1, 309–327 (2005).CrossRefGoogle Scholar
  3. 3.
    E. C. Webb, Enzyme Nomenclature, Academic Press, San Diego (1992).Google Scholar
  4. 4.
    G. D. Jones, L. Russell, V. M. Darley-Usmar, D. Stone, and M. T. Wilson, Biochemistry, 35, 7197–7203 (1996).PubMedCrossRefGoogle Scholar
  5. 5.
    H. Tapiero, D. Townsend, and K. Tew, Biomed. Pharmacother., 58, 183–193 (2004).PubMedCrossRefGoogle Scholar
  6. 6.
    L. A. Tyurina, O. V. Tyurina, and A. M. Kolbin, Methods and Results of the Design and Prediction of Biologically Active Compounds [in Russian], Gilem, Ufa (2007).Google Scholar
  7. 7.
    E. Block, R. Iyer, S. Grisoni, et al., J. Am. Chem. Soc., 110, 7813–7827 (1988).CrossRefGoogle Scholar
  8. 8.
    S. T. Prigge, J. S. Boyington, M. Faig, and K. S. Doctor, Biochimie, 79, 629–636 (1997).PubMedCrossRefGoogle Scholar
  9. 9.
    Y. Vasques-Martinez, R. V. Ohri, V. Kenyon, and T. R. Holman, Bioorg. Med. Chem., 15, 7408–7425 (2007).CrossRefGoogle Scholar
  10. 10.
    A. B. Camargo and E. Marchevsky, J. Agric. Food Chem., 55, 3096–3103 (2007).PubMedCrossRefGoogle Scholar
  11. 11.
    D. S. Weinstein, W. Liu, K. Ngu, et al., Bioorg. Med. Chem. Lett., 17, 5115–5120 (2007).PubMedCrossRefGoogle Scholar
  12. 12.
    P. N. P. Rao, Q.-H. Chen, and E. E. Knaus, J. Med. Chem., 49, 1668–1683 (2006).PubMedCrossRefGoogle Scholar
  13. 13.
    U. P. Singh, B. Prithiviraj, B. K. Sarma, et al., Indian J. Exp. Biol., 39, 310–322 (2001).PubMedGoogle Scholar
  14. 14.
    U. P. Kelavkar,W. Glasgow, S. J. Olson, and B. A. Foster, Neoplasia, 6, 821–830 (2004).PubMedGoogle Scholar
  15. 15.
    R. J. Hsieh, J. B. German, and J. E. Kinsella, Lipids, 23, 322–326 (1988).PubMedCrossRefGoogle Scholar
  16. 16.
    O. Werz, B. Szellas, and D. Steinhilber, Eur. J. Biochem., 267, 1263–1269 (2000).PubMedCrossRefGoogle Scholar
  17. 17.
    E. T. Denisov and I. B. Afanas?ev, Oxidation and Antioxidants in Organic Chemistry and Biology, Talyor & Francis, Boca Raton (2005).Google Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • V. R. Khairullina
    • 1
  • I. A. Taipov
    • 1
  • A. Ya. Gerchikov
    • 1
  • F. S. Zarudii
    • 2
  1. 1.Bashkir State UniversityUfaRussia
  2. 2.Bashkir State Medical UniversityUfaRussia

Personalised recommendations